Searchable abstracts of presentations at key conferences in endocrinology

ea0031p361 | Thyroid | SFEBES2013

Factors predicting the development of hypothyroidism after radioactive iodine treatment

Varghese Jeanny , Aye Mo , Wright Graham , Rigby A , England James , Sathyapalan Thozhukat , Atkin Stephen

Background: The use of radioactive iodine treatment (RAI) for the definitive treatment of benign hyperthyroid disorders has been well established. This study was conducted to determine the factors predicting the development of hypothyroidism following RAI therapy.Methods: All patients (n=104, 25 men, 79 women) who had RAI for hyperthyroidism between January 2008 and December 2009 were included. In 82.6% of patients antithyroid medications were u...

ea0028p127 | Clinical practice/governance and case reports | SFEBES2012

A case of normocalcaemic hyperparathyroidism

Konya Judit , Kahal Hassan , Wakil Ammar , Sathyapalan Thozhukat , Atkin Stephen , Aye Mo

Introduction: Normocalcemic hyperparathyroidism is a less recognised variation of primary hyperparathyroidism (pHPT). Patients present with normal calcium and elevated level of PTH.Case: A 70 years old woman presented to her general practitioner with left sided loin pain. She had no past medical history of note and she was not taking any medications. Ultrasound of the urinary tract showed bilateral nephrocalcinosis. Her blood tests showed raised PTH leve...

ea0028p132 | Cytokines and growth factors | SFEBES2012

Effect of rimonabant and metformin on inflammatory cytokines in obese women with polycystic ovary syndrome

Konya Judit , Sathyapalan Thozhukat , Cho Li Wei , Coady Anne , Kilpatrick Eric , Atkin Stephen

Introduction: Polycystic ovary syndrome (PCOS) has shown to be associated with increased levels of pro-inflammatory cytokines. This study was undertaken to determine the changes of pro-inflammatory cytokines in patients with PCOS after rimonabant and/or metformin treatment.Methods: A 3 month randomised open labelled parallel study of rimonabant or metformin in 20 patients with PCOS with a body mass index >30 kg/m2 was undertaken. Subsequen...

ea0025p265 | Reproduction | SFEBES2011

The effect of atorvastatin on adrenal and ovarian hyperandrogenemia in patients with polycystic ovary syndrome.

Sathyapalan Thozhukat , Smith Karen A , Coady Anne-Marie , Kilpatrick Eric S , Atkin Stephen L

Context: Hyperandrogenemia in polycystic ovary syndrome (PCOS) represents a composite of raised serum concentrations of testosterone, androstenedione, dehydroepiandrosterone (DHEA), and DHEA sulfate (DHEAS). In patients with PCOS, testosterone and androstenedione are primarily derived from the ovaries and DHEAS is a metabolite predominantly from the adrenals. It has been shown that atorvastatin reduces testosterone levels in patients with PCOS.Objective:...

ea0025p326 | Thyroid | SFEBES2011

The effect of parathyroidectomy on neuropsychological symptoms in patients with asymptomatic primary hyperparathyroidism

Kahal Hassan , Aye Mo , Rigby Alan , Sathyapalan Thozhukat , England James , Atkin Stephen

Introduction: With increased biochemical screening primary hyperparathyroidism (pHPT) is discovered incidentally while patients are still asymptomatic.Objective: To assess the impact of surgery on neuropsychological symptoms in people with apparent asymptomatic pHPT.Methods: Twenty-four patients with asymptomatic pHPT requiring parathyroidectomy, in accordance with NIH recommendations, were recruited prospectively between May 2005 ...

ea0025p351 | Thyroid | SFEBES2011

Thyroid dysfunction in patients receiving interferon treatment for hepatitis C: an audit

Sugunendran Suma , Verghese Jeanny , Aye Mo , Sathyapalan Thozhukat , Abouda George , Mohamed Kamrudeen

Aims and objective: Pegylated interferon is widely used in the treatment of hepatitis C. Thyroid dysfunction (TD) is a well recognised side effect of interferon treatment. As the use of interferon therapy in hepatitis C is on the rise, we conducted an audit to determine its prevalence and to formulate local guidelines for the monitoring and management of thyroid dysfunction in these patients.Methods: A case note based retrospective audit of all patients ...

ea0015p280 | Reproduction | SFEBES2008

A comparison between rimonabant and metformin in reducing metabolic parameters including hyperandrogenemia in patients with polycystic ovarian syndrome: a randomised open labelled parallel study

Sathyapalan Thozhukat , Cho Li Wei , Kilpatrick Eric S , Coady Anne-Marie , Atkin Stephen L

Context: Weight loss and metformin therapy are beneficial in improving the hormonal and metabolic consequences of PCOS. Rimonabant has been found to reduce weight and improve the metabolic profile in patients with metabolic syndrome.Objective: To compare the effects of metformin and rimonabant on insulin resistance and biochemical hyperandrogenemia.Subjects: Twenty patients with PCOS and biochemical hyperandrogenemia were recruited...

ea0015p283 | Reproduction | SFEBES2008

Rimonabant is more effective in patients with metabolic syndrome compared to patients without metabolic syndrome in polycystic ovary syndrome

Sathyapalan Thozhukat , Chow Li Wei , Kilpatrick Eric S , Coady Anne-Marie , Atkin Stephen L

Context: Rimonabant has been found to reduce weight and improve the metabolic profile in patients with metabolic syndrome as well as PCOS.Objective: To compare the effects of metformin and rimonabant in patients with PCOS with and without metabolic syndrome according to ATP III criteria.Design: A randomised open labelled parallel study comparing the effects on rimonabant and metformin in patients with PCOS.Su...

ea0094p303 | Adrenal and Cardiovascular | SFEBES2023

The hidden duo: phaeochromocytoma and primary peritoneal metastatic carcinoma unmasked

Akbar Shahzad , Taqi Muhammad , Karim Rehmat , Deshmukh Harshal , Aye Mo , Sathyapalan Thozhukat , Mongolu Shiva

A 71-year-old woman was referred to the urology department with macroscopic haematuria. An ultrasound scan revealed a suspicious solid mass measuring 6.6cm arising from the left kidney. Subsequent CT scan confirmed the presence of a left adrenal mass along with omental and peritoneal disease and small-volume ascites. The patient was referred to the adrenal surgeons for consideration of left adrenalectomy in view of suspected adrenal cancer. At the surgical outpatient departmen...

ea0077p237 | Reproductive Endocrinology | SFEBES2021

Impact of pharmacological Interventions on androgen hormones in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials

Abdalla Mohammed , Shah Najeeb , Deshmukh Harshal , Sahebkar Amirhossein , Ostlundh Linda , Al-Rifai Rami H , Atkin Stephen L , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) is a complex endocrine disease that affects women of reproductive age and characterised by biochemical and clinical androgen excess.Aim: To review the available literature on the effectiveness of the various pharmacological interventions on androgen hormones in women with PCOS.Data source: We searched PubMed, MEDLINE, Scopus, Embase, Cochrane library and the Web of Science in April 2020 and...